Perigon Wealth Management, LLC Amphastar Pharmaceuticals, Inc. Transaction History

Perigon Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$42.85 - $63.45 $295,107 - $436,980	-6,887 Reduced 56.91%	5,215 $228,000
Q4 2023 Jan 29, 2024	BUY	$44.49 - $62.93 $325,622 - $460,584	7,319 Added 153.02%	12,102 $748,000
Q3 2023 Oct 30, 2023	BUY	$45.51 - $65.0 $546 - $780	12 Added 0.25%	4,783 $219,000
Q2 2023 Aug 02, 2023	SELL	$35.77 - $58.38 $117,289 - $191,428	-3,279 Reduced 40.73%	4,771 $274,000
Q1 2023 May 03, 2023	BUY	$27.99 - $37.92 $5,598 - $7,584	200 Added 2.55%	8,050 $301,000
Q3 2022 Dec 13, 2022	BUY	$27.56 - $37.75 $216,346 - $296,337	7,850 New	7,850 $221,000
Q3 2011 Nov 14, 2022	BUY	N/A	7,850	7,850 $221,000

286

34.9M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Perigon Wealth Management, LLC with notifications on news.